(Q44183110)

English

ZD1839 (Iressa): an orally active inhibitor of epidermal growth factor signaling with potential for cancer therapy.

scientific article published in October 2002

Statements

ZD1839 (Iressa): an orally active inhibitor of epidermal growth factor signaling with potential for cancer therapy (English)

Identifiers

 
edit
    edit
      edit
        edit
          edit
            edit
              edit
                edit
                  edit